Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis

  • Arnon D. Cohen
  • , Dafnah Hallel-Halevy
  • , Lev Hatskelzon
  • , Eyal Peretz
  • , Sima Halevy

    Research output: Contribution to journalArticlepeer-review

    10 Scopus citations

    Abstract

    Occurrence of skin lesions during long-term therapy with hydroxyurea are well described, but there have been only a few case reports of longitudinal melanonychia associated with hydroxyurea treatment. We report herein longitudinal melanonychia associated with hydroxyurea therapy in a subject with essential thrombocytosis. The prolonged time lapse (1 year) between initiation of hydroxyurea therapy and the onset of the longitudinal melanonychia should be noted. Copyright (C) 1999 Elsevier Science B.V.

    Original languageEnglish
    Pages (from-to)137-139
    Number of pages3
    JournalJournal of the European Academy of Dermatology and Venereology
    Volume13
    Issue number2
    DOIs
    StatePublished - 19 Oct 1999

    Keywords

    • Essential thrombocytosis
    • Hydroxyurea therapy
    • Melanonychia

    ASJC Scopus subject areas

    • Dermatology
    • Infectious Diseases

    Fingerprint

    Dive into the research topics of 'Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis'. Together they form a unique fingerprint.

    Cite this